MEK inhibition activates STAT signaling to increase breast cancer immunogenicity via MHC-I expression

Abstract

These findings suggest that MAPK signaling and STAT activation are inversely related in both mouse and human mammary tumors. This work also supports further study of MEKi to increase STAT signaling and potentially, immunotherapy responses through increased MHC-I and PD-L1 expression.